Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cryopreservation of female reproductive potential.

Gook DA, Edgar DH.

Best Pract Res Clin Obstet Gynaecol. 2019 Feb;55:23-36. doi: 10.1016/j.bpobgyn.2018.08.005. Epub 2018 Aug 31. Review.

PMID:
30249473
2.

Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.

Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.

Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4.

PMID:
26848188
3.

Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.

Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, Morimoto Y, Kawamura K.

Hum Reprod. 2015 Mar;30(3):608-15. doi: 10.1093/humrep/deu353. Epub 2015 Jan 6.

PMID:
25567618
4.

Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M.

Fertil Steril. 2019 Feb;111(2):357-362. doi: 10.1016/j.fertnstert.2018.10.018. Epub 2018 Dec 7.

PMID:
30527837
5.

Cryobiology in human assisted reproductive technology. Would Hippocrates approve?

Bredkjaer HE, Grudzinskas JG.

Early Pregnancy. 2001 Jul;5(3):211-3.

PMID:
11753534
6.

Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation.

Fasano G, Moffa F, Dechène J, Englert Y, Demeestere I.

Reprod Biol Endocrinol. 2011 Nov 23;9:150. doi: 10.1186/1477-7827-9-150.

7.

In vitro maturation of human immature oocytes for fertility preservation.

Chian RC, Uzelac PS, Nargund G.

Fertil Steril. 2013 Apr;99(5):1173-81. doi: 10.1016/j.fertnstert.2013.01.141. Epub 2013 Feb 20. Review.

PMID:
23433515
8.

What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?

Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, Grynberg M.

Hum Reprod. 2016 Jul;31(7):1493-500. doi: 10.1093/humrep/dew102. Epub 2016 May 10.

PMID:
27165625
9.
10.

Fertility preservation in women after the cancer.

Lappi M, Borini A.

Curr Pharm Des. 2012;18(3):293-302. Review.

PMID:
22229566
11.

Female fertility preservation: past, present and future.

Fisch B, Abir R.

Reproduction. 2018 Jul;156(1):F11-F27. doi: 10.1530/REP-17-0483. Epub 2018 Mar 26. Review.

PMID:
29581237
12.

Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?

Lee JA, Barritt J, Moschini RM, Slifkin RE, Copperman AB.

Fertil Steril. 2013 Apr;99(5):1356-62. doi: 10.1016/j.fertnstert.2012.11.042. Epub 2012 Dec 21.

PMID:
23266213
13.

Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.

Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N.

Hum Reprod. 2016 Mar;31(3):623-9. doi: 10.1093/humrep/dev325. Epub 2016 Jan 11.

PMID:
26759139
14.

Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.

Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, Cobo A, Remohí J, Pellicer A.

Fertil Steril. 2018 Mar;109(3):478-485.e2. doi: 10.1016/j.fertnstert.2017.11.018. Epub 2018 Feb 7.

PMID:
29428307
15.

Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.

Creux H, Monnier P, Son WY, Tulandi T, Buckett W.

Fertil Steril. 2017 Jan;107(1):198-204. doi: 10.1016/j.fertnstert.2016.09.041. Epub 2016 Oct 31.

PMID:
27810160
16.

Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.

Hourvitz A, Yerushalmi GM, Maman E, Raanani H, Elizur S, Brengauz M, Orvieto R, Dor J, Meirow D.

Reprod Biomed Online. 2015 Oct;31(4):497-505. doi: 10.1016/j.rbmo.2015.06.025. Epub 2015 Jul 13.

PMID:
26278808
17.

Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.

Danis RB, Pereira N, Elias RT.

Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531. Review.

PMID:
28786354
18.

[Fertility preservation in women of the childbearing age: Indications and strategies].

Bénard J, Calvo J, Comtet M, Benoit A, Sifer C, Grynberg M.

J Gynecol Obstet Biol Reprod (Paris). 2016 May;45(5):424-44. doi: 10.1016/j.jgyn.2016.02.005. Epub 2016 Mar 22. Review. French.

19.

Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue.

Yin H, Jiang H, Kristensen SG, Andersen CY.

J Assist Reprod Genet. 2016 Jun;33(6):741-6. doi: 10.1007/s10815-016-0691-7. Epub 2016 Mar 17.

20.

Supplemental Content

Support Center